Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Natalia Kurepina"'
Autor:
Luigi Xerri, Antonio Oliver, Cassandra L Chatwin, Cornelius J. Clancy, Barry N. Kreiswirth, Daniel Pevear, Minh-Hong Nguyen, Denis M. Daigle, Natalia Kurepina, Jodie Hamrick, Ryan K. Shields
Publikováno v:
Open Forum Infectious Diseases
Background VNRX-5133 is a cyclic boronate β-lactamase inhibitor (BLI) currently in clinical development with cefepime to treat multidrug-resistant (MDR) infections caused by ESBL- and carbapenemase-producing Enterobacteriaceae (ENT) and P. aeruginos
Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community
Autor:
Elena Shashkina, Barun Mathema, Landon Myer, Andrew Whitelaw, Barry N. Kreiswirth, Linda-Gail Bekker, Keren Middelkoop, Gilla Kaplan, Robin Wood, Natalia Kurepina
Background: Factors associated with Mycobacterium tuberculosis (Mtb) strain success over time in high burdened communities are unknown. Methods: Mtb isolates collected over 10 years from sputum-positive tuberculosis (TB) patients resident in the stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d6acc33d6b72226766d2fa78f22b59
https://europepmc.org/articles/PMC4121554/
https://europepmc.org/articles/PMC4121554/